What do the numbers say about Tata Chemicals Ltd. (TATACHEM)? Here's a look at its financials, valuation, and ownership data.
Tata Chemicals Revenue Trend
Top-line pressure showed for Tata Chemicals Ltd., with revenue declining 1.4% to ₹14,900 Cr in FY2026.
Over the past 10 years, revenue has declined at a 1.7% annual rate, from ₹17,708 Cr to ₹14,900 Cr. A slow bleed, but still a declining trend.
Tata Chemicals Ltd.'s ₹14,900 Cr revenue base puts it in the major bracket among chemicals - inorganic companies in India.
The consistency stands out: 3 consecutive years of decline in top-line revenue.
| Year | Revenue | YoY % |
|---|---|---|
| FY2026 | ₹14,900 Cr | -1.4% |
| FY2025 | ₹15,112 Cr | -3.8% |
| FY2024 | ₹15,707 Cr | -7.6% |
| FY2023 | ₹17,007 Cr | +32.1% |
| FY2022 | ₹12,878 Cr | — |
View Tata Chemicals Ltd.'s full 10-year revenue trend with CAGR analysis →
Tata Chemicals Profitability
Tata Chemicals Ltd. slipped into the red in FY2026, posting a net loss of ₹1,715 Cr against a profit of ₹387 Cr a year earlier.
Per-share earnings moved to ₹-74.42 in FY2026 from ₹9.23 in FY2025.
Is Tata Chemicals Undervalued
The P/E Ratio valuation pegs Tata Chemicals Ltd.'s fair value at ₹755, which is 5.7% upside from the current price.
Tata Chemicals Ltd. shares are currently trading at ₹714.40.
Craytheon also calculates intrinsic value using the EPS Growth model. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹755 | 5.7% upside to fair value |
| EPS Growth | Upgrade | Upgrade |
See all valuation models for Tata Chemicals Ltd. with detailed assumptions →
Tata Chemicals Shareholding Pattern
Promoter holding is steady at 38.0% — no buying or selling over the past 4 quarters.
Foreign investors held 11.9% of the company as of March 2026, down year-over-year from 12.8%.
DII holding is at 22.8%, up from 22.6% in the year-ago quarter.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Mar 2026 | 38.0% | 11.9% | 22.8% | 27.2% |
| Dec 2025 | 38.0% | 12.3% | 22.4% | 27.3% |
| Sep 2025 | 38.0% | 13.7% | 22.2% | 26.1% |
| Jun 2025 | 38.0% | 12.8% | 22.6% | 26.5% |
Track quarterly shareholding changes for Tata Chemicals Ltd. →
Tata Chemicals Balance Sheet
Proportional view as of 13 Jul 2026. Hover blocks for details.
Assets
Liabilities & Equity
Total assets stood at ₹390.31B at the end of FY2026, up 3.3% from ₹377.80B a year earlier.
Property, Plant & Equipment is the largest block at 28.0%, followed by Intangibles & Goodwill at 25.3% and Investments at 23.5%.
Equity makes up 56.8% of liabilities and equity, with debt at 20.5% and operating liabilities at 22.7%. Over the year, debt is up 13.1% and equity is down 1.4%.
Balance sheet composition — FY 2026
| Category | Value |
|---|---|
| Cash & ST Investments | 10.92B |
| Receivables | 20.88B |
| Inventories | 30.82B |
| Property, Plant & Equipment | 109.34B |
| Investments | 91.75B |
| Intangibles & Goodwill | 98.63B |
| Other Assets | 27.97B |
| Category | Value |
|---|---|
| Equity | 221.75B |
| Short-term Debt | 26.24B |
| Long-term Debt | 53.77B |
| Trade Payables | 25.52B |
| Other Liabilities | 63.03B |
Tata Chemicals — The Bottom Line
Bringing the key threads together for Tata Chemicals Ltd. (TATACHEM) as a chemicals - inorganic investment opportunity.
Revenue of ₹14,900 Cr in FY2026, down 1.4% year-over-year.
Long-term revenue has been contracting at 1.7% annually over 10 years.
The company reported a net loss of ₹1,715 Cr in FY2026.
The P/E Ratio model implies 5.7% upside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
Want to dig deeper? Craytheon's platform provides 10 years of financial data, three valuation models, and insider trading activity for Tata Chemicals Ltd..